اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 17, Issue 3 (بهار 1395: جلد 17. شماره 3 1395) ::
Koomesh 1395, 17(3): 603-612 Back to browse issues page
Correlation between JAK2V617F mutation and inflammatory bowel disease in patients referring to Taleghani hospital, Tehran
Khadijeh Koushki , Mohammad Rostami Nejad , Pedrami Azimzadeh , Hamid Asadzadeh Aghdaei , Abas Hajfathali , Mohammad Amin Pourhosseingholi , Hedyeh Balaei , Davar Amani , Mohammad Reza Zali , Hossein Nobakht
Abstract:   (5770 Views)
Introduction: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory disorder of the gastrointestinal tract. Genome-wide association study (GWAS) has shown that some of the genes of interleukin-23/T-helper 17 (IL-23/Th17) pathway such as Janus kinase -2 (JAK2) predispose the risk of IBD. 46/1 haplotype is common risk factors for both IBD and myeloproliferative neoplasms disease. In view of this shared genetic predisposition, we aimed to determine the frequency of the JAK2V617F mutation in Iranians with IBD for the first time. Materials and methods: In this case-control study, 100  IBD patients including 18 with CD and 82 UC were compared with 100 healthy controls  during 2011-2014. The genotypes were identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) protocols and distribution of the JAK2 V617F mutations were compared in cases and control. To verify the method, patients with myeloproliferative neoplasms with JAK2V617F mutations were served as controls. Results: This study showed that JAK2V617F mutation was detected in neither patients nor controls. However, mutation was proved in all patients with myeloproliferative neoplasms that were used as positive control and their heterogeneities were determined. Conclusion: This study showed that other genetic mechanisms may play an important role in the pathogenesis of IBD. For further evaluation of this mutation, other studies with a larger number of patients and complications such as thromboembolic diseases, is recommended
Keywords: Inflammatory Bowel Disease, Mutation, Janus Kinase 2
Full-Text [PDF 812 kb]   (2016 Downloads)    
Type of Study: Research | Subject: General
Received: 2015/09/19 | Accepted: 2015/12/22 | Published: 2016/03/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

koushki K, Rostami Nejad M, Azimzadeh P, Asadzadeh Aghdaei H, Hajfathali A, Pourhosseingholi M A, et al . Correlation between JAK2V617F mutation and inflammatory bowel disease in patients referring to Taleghani hospital, Tehran. Koomesh 1395; 17 (3) :603-612
URL: http://koomeshjournal.semums.ac.ir/article-1-3037-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 17, Issue 3 (بهار 1395: جلد 17. شماره 3 1395) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645